In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Lead Optimization
Instem Team
Unifying Science and Safety to Navigate the Iterative Path of Lead Optimization
In Silico & Data Insights Blog
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Discovery
Instem Team
Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Target Identification
Instem Team
With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.
In Silico & Data InsightsLeadscopeRegulatory Submission
My Thoughts on NAMs and the Future of Drug Development: Progress Demands Leadership
Instem Team
NAMs have the potential to deliver more efficient safety assessments, enabling faster and more confident development decisions while also supporting more ethical drug development.
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule: Why Integration Matters in Modern Drug Development
Instem Team
Every breakthrough begins with a single molecule. Follow the journey from early research to regulatory submission and learn how Instem helps teams work more efficiently, reduce risk, and deliver safer, more effective therapies to patients...
CROIn Silico & Data InsightsPre-ClinicalPress ReleasesStudy ManagementSubmit
Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution
Mike Thurogood, CMktr
Instem is reaffirming its role as the industry’s trusted provider of an end-to-end preclinical platform.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
